DJIA: 30,391.60 +167.71 (0.55%) | NASDAQ: 12,818.96
DJIA: 30,391.60 +167.71 (0.55%) | NASDAQ: 12,818.96 +120.513 (0.95%) |
Read this see what everyone thinks. Last Paragraph
S&P 500: 3,726.86 +26.21 (0.71%) —Markets closed
Print | Help/Glossary
Learn how to evaluate a company's health with our Fundamental Analysis education.
Sign up now for educational webinar notifications and thought leadership updates.
Join us for In the Money with options strategist and CNBC contributor Dan Nathan for a weekly take on the market. Watch now.
Snapshot:UNVC
UNIVEC CONGLOMERATE INC
0.03Up 0.00 (0.00 %)AS OF 3:59:34PM ET 01/05/2021
Quotes delayed at least 15 min. Log in for real time quote.
Trade Add to Watch List Set Alert Hypothetical Trade Price History down
Bid 0.028
Bid Size 0
Ask 0.032
Ask Size 0
Open 0.029
Day High 0.032
Day Low 0.028
Previous Close 0.03
52-Week High 0.04
01/04/2021
52-Week Low 0.0029
01/15/2020
Price Performance (Last 52 Weeks) +233.33%
Held by ETPs
No
Volume 3,385,964
90-Day Average Volume 2,024,240
Primary Exchange OTC Markets
Index Not In
S&P 500®
DJIA®
NASDAQ 100®
Options
No
Detailed Quote
Reset Chart
Advanced Chart
Save
DrawIndicatorsEventsCompareSettings
0.03
UNVC
UNIVEC CONGLOMERATE INC
02/03/2020
04/01/2020
06/01/2020
08/03/2020
10/01/2020
12/01/2020
2020
2021
0M
10M
20M
0.0000
0.0200
0.0400
0.0600
0.03
Volume 3,385,964
01/05/2021 O: 0.0290 H: 0.0320 L: 0.0280 C: 0.0300
TODAY 2D 5D 10D 1M 3M 6M YTD 1Y 3Y 5Y 10Y Frequency
AILY
AS OF 4:00 PM ET 01/05/2021
News & EventsLog in for more news
Error UNVC currently has no news.
No Events UNVC currently has no events.
Events
More News & Events
Company ProfileLog in for more information
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.
https://eresearch.fidelity.com/eresearch/goto...mbols=UNVC
TOODLES
6
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...
Continue Reading
Mixed pathology is where Alzheimer's investing gets uncomfortably real, and this new lecanemab readout is a decent reminder that a drug can show promise without settling the argument. Eisai and Biogen presented a Clarity AD cerebrospinal-fluid substudy at CTAD 2026 examining people with early Alzheimer's disease who also tested positive for alpha-synuclein pathology. The...
Continue Reading
A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...
Continue Reading
Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...
Continue Reading
Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...
Continue Reading
Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...
Continue Reading
Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....
Continue Reading
Software agents without decent business context are just eager interns with access to the keyboard. SOCi’s November 19, 2026 announcement gets at that unglamorous truth: the company has made its Model Context Protocol server generally available and says its context layer now connects with more than 140 integrations. It is not a flashy new chatbot stunt. It is a bid to...
Continue Reading
An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...
Continue Reading
Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...
Continue Reading
Top 5 Most Recently Viewed Articles
MAGNA-TILES Innovates Play with Rail Racers Launch First Fan-Made Invention Reimagines Ball Runs and Takes Magnetic Building to the Next Level MAGNA-TILES, America’s favorite magnetic building toy brand, has introduced an exciting innovation—the Rail Racers. This remarkable new product debuted at the American International Toy Fair, showcasing the creativity of the...
Continue Reading
Unlocking the Future of Bitcoin Mining DDB Miner, a forward-thinking Bitcoin mining entity, is making significant strides in the cryptocurrency industry. By emphasizing low-cost and efficient operations, DDB Miner is set on a path to redefine how Bitcoin is mined. Their latest operational update sheds light on impressive developments and ambitious plans that promise to...
Continue Reading
Warren Buffett Speeds Up Charitable Contributions Warren Buffett recently announced that he will accelerate the distribution of his vast fortune, amounting to $149 billion, to his children's charitable foundations. This strategic decision aligns with the responsibilities he feels as a father, recognizing the increasing ages of his children. The Transition to Greg Abel As...
Continue Reading
DeFi Technologies Class Action Explained Robbins LLP recently brought to light a class action lawsuit on behalf of investors who bought or acquired shares of DeFi Technologies Inc. (NASDAQ: DEFT). This action covers a specific timeframe, reflecting concerns over the company’s alleged misrepresentation of its business prospects. Investors seeking clarity on this...
Continue Reading
Alibaba's Bold Move into Robotics Alibaba Group (NYSE: BABA) has embarked on an exciting new venture by launching its own robotics team to compete in the rapidly advancing field of AI-powered physical products. This initiative reflects Alibaba's commitment to integrating artificial intelligence into everyday applications, transforming how technology interacts with the...
Continue Reading